TipRanks
Advertisement
Advertisement

NSRX Stock Latest News

Nasus Pharma Shareholders Approve Most Proposals at October Annual and Special Meeting
Company AnnouncementsNasus Pharma Shareholders Approve Most Proposals at October Annual and Special Meeting
5d ago
6K
NSRX
Nasus Pharma announces first patient enrolled, dosed in Phase 1 trial of NS003
PremiumThe Fly
Nasus Pharma announces first patient enrolled, dosed in Phase 1 trial of NS003
14d ago
NSRX
Nasus Pharma Sets Up $8.5 Million At-the-Market Equity Program to Fund Clinical Pipeline
PremiumCompany Announcements
Nasus Pharma Sets Up $8.5 Million At-the-Market Equity Program to Fund Clinical Pipeline
25d ago
6K
NSRX
Nasus Pharma Wins FDA Clearance to Begin NS002 Anaphylaxis Trial
PremiumCompany Announcements
Nasus Pharma Wins FDA Clearance to Begin NS002 Anaphylaxis Trial
29d ago
6K
NSRX
Nasus Pharma Sets October 8, 2026 Shareholder Meeting to Vote on Governance, Executive Pay and Option Pool
PremiumCompany Announcements
Nasus Pharma Sets October 8, 2026 Shareholder Meeting to Vote on Governance, Executive Pay and Option Pool
1M ago
6K
NSRX
Nasus Pharma files $50M ordinary shares offering
PremiumThe FlyNasus Pharma files $50M ordinary shares offering
1M ago
NSRX
Nasus Pharma Names Interim CFO as Longtime Finance Chief Resigns
Premium
Company Announcements
Nasus Pharma Names Interim CFO as Longtime Finance Chief Resigns
2M ago
6K
NSRX
Nasus Pharma Boosts Cash and Equity in First-Half 2026 Filing
Premium
Company Announcements
Nasus Pharma Boosts Cash and Equity in First-Half 2026 Filing
2M ago
6K
NSRX
Nasus Pharma Installs Industry Veteran Brendan O’Grady as CEO to Steer Next Growth Phase
PremiumCompany Announcements
Nasus Pharma Installs Industry Veteran Brendan O’Grady as CEO to Steer Next Growth Phase
3M ago
6K
NSRX
Nasus Pharma appoints Brendan O’Grady as CEO
PremiumThe Fly
Nasus Pharma appoints Brendan O’Grady as CEO
3M ago
NSRX
Nasus Pharma Advances Intranasal Ondansetron After Positive Preclinical Data
PremiumCompany Announcements
Nasus Pharma Advances Intranasal Ondansetron After Positive Preclinical Data
4M ago
6K
NSRX
Nasus Pharma price target lowered to $18 from $19 at Citizens
PremiumThe Fly
Nasus Pharma price target lowered to $18 from $19 at Citizens
7M ago
NSRX
Nasus Pharma Moves Intranasal Epinephrine Toward Pivotal Trial After Positive Phase 2 Results
PremiumCompany AnnouncementsNasus Pharma Moves Intranasal Epinephrine Toward Pivotal Trial After Positive Phase 2 Results
7M ago
6K
NSRX
Nasus Pharma advances NS002 to pivotal study following Phase 2 results
Premium
The Fly
Nasus Pharma advances NS002 to pivotal study following Phase 2 results
7M ago
NSRX
Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)
Premium
TipRanks Newswire
Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)
7M ago
SER
NSRX
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
PremiumTipRanks Newswire
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
7M ago
CTMX
NSRX
Nasus Pharma’s NS002 Outperforms EpiPen in Phase 2 Anaphylaxis Study, Pivotal Trial Planned for Late 2026
PremiumCompany Announcements
Nasus Pharma’s NS002 Outperforms EpiPen in Phase 2 Anaphylaxis Study, Pivotal Trial Planned for Late 2026
7M ago
6K
NSRX
Nasus Pharma announces topline data from Phase 2 clinical study of NS002
PremiumThe Fly
Nasus Pharma announces topline data from Phase 2 clinical study of NS002
7M ago
NSRX
Nasus Pharma Shareholders Approve Capital Increase and Amended Articles at March 5 Meeting
PremiumCompany Announcements
Nasus Pharma Shareholders Approve Capital Increase and Amended Articles at March 5 Meeting
7M ago
6K
NSRX
Nasus Pharma Moves March 5 Shareholder Meeting to Virtual-Only Format Amid Israel Security Situation
PremiumCompany AnnouncementsNasus Pharma Moves March 5 Shareholder Meeting to Virtual-Only Format Amid Israel Security Situation
7M ago
6K
NSRX
Nasus Pharma files to sell 5.39M ordinary shares for holders
Premium
The Fly
Nasus Pharma files to sell 5.39M ordinary shares for holders
7M ago
NSRX
Nasus Approaches Key Data Readout That Could Reshape the Multi Billion Dollar Epinephrine Market (NYSE: NSRX)
Premium
TipRanks Newswire
Nasus Approaches Key Data Readout That Could Reshape the Multi Billion Dollar Epinephrine Market (NYSE: NSRX)
8M ago
NSRX
XERS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >